Facebook
Twitter
Telegram
Fehler meldenSage Therapeutics Finanzdaten 2011-2024 | SAGE
Jahresabschluß Sage Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
1.54 B | 2.65 B | 2.5 B | 4.5 B | 3.4 B | 6.12 B | 7.04 B | 1.54 B | 933 M | 871 M | - | - | - |
Anteile |
59.8 M | 59.3 M | 58.7 M | 52 M | 50.8 M | 46.1 M | 38.1 M | 33.5 M | 27.8 M | 21.6 M | - | - | - |
Kurshistorie |
25.7 | 44.7 | 42.5 | 86.5 | 72.2 | 95.8 | 165 | 51.1 | 58.3 | 36.6 | - | - | - |
Nettogewinn |
-541 M | -533 M | -458 M | 606 M | -680 M | -373 M | -270 M | -159 M | -94.5 M | -33.8 M | -18.3 M | -9.63 M | - |
Umsatz |
86.5 M | 7.69 M | 6.31 M | 1.11 B | 6.87 M | 90.3 M | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | 6.47 M | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-580 M | -547 M | -461 M | 596 M | -708 M | -393 M | -273 M | -160 M | -94.6 M | -33.8 M | -18.3 M | -9.63 M | - |
Zinsaufwendungen |
-383 K | 15 K | 134 K | 250 K | 82 K | 22 K | -64 K | -35 K | -23 K | -9 K | -3 K | -1 K | - |
EBITDA |
-578 M | -546 M | -457 M | 599 M | -706 M | -392 M | -273 M | -160 M | -94.5 M | -33.8 M | -18.2 M | -9.59 M | - |
Betriebsaufwand |
666 M | 555 M | 467 M | 518 M | 715 M | 484 M | 273 M | 160 M | 94.6 M | 33.8 M | - | - | - |
Allgemeine und Verwaltungsausgaben |
275 M | 228 M | 183 M | 197 M | 346 M | 157 M | 51.7 M | 34.1 M | 22.2 M | 9.71 M | 3.38 M | 2.4 M | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Sage Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
60.1 M | 60 M | 59.9 M | 59.8 M | 59.7 M | 59.5 M | 59.4 M | 59.3 M | 59 M | 58.9 M | 58.8 M | 58.6 M | 58.4 M | 58.3 M | 52 M | 51.9 M | 51.9 M | 51.9 M | 51.7 M | 51.3 M | 48.5 M | 46.9 M | 46.7 M | 46.5 M | 44.3 M | 42 M | 37.5 M | 37.4 M | 37.3 M | 37.2 M | 33 M | 32.1 M | 31.6 M | 28.8 M | 28.7 M | 27.9 M | 25.7 M | 25.6 M | 19.6 M | 1.7 M | 1.65 M | 1.62 M | 1.51 M | 1.46 M | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-108 M | - | -202 M | -160 M | -147 M | - | -137 M | -126 M | -122 M | - | -130 M | -107 M | -95.8 M | 975 M | -106 M | -136 M | -127 M | -169 M | -180 M | -168 M | -163 M | -158 M | -123 M | -17 M | -74.6 M | -69.4 M | -73.7 M | -70.2 M | -56.8 M | -55.9 M | -37.8 M | -34.7 M | -30.5 M | -28.6 M | -24 M | -25 M | -16.9 M | -12.4 M | -9.47 M | -6.19 M | -5.79 M | - | -4.52 M | -4.66 M | - | - | - | - | - | - | - | - | - |
Umsatz |
7.9 M | - | 2.72 M | 2.47 M | 3.29 M | - | 1.74 M | 1.5 M | 1.58 M | - | 1.44 M | 1.64 M | 1.58 M | 1.11 B | 1.64 M | 1.09 M | 2.29 M | 1.96 M | 3.57 M | 873 K | 465 K | 273 K | 90 M | 90 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 44 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-118 M | - | -212 M | -170 M | -155 M | - | -141 M | -128 M | -123 M | - | -131 M | -108 M | -96.5 M | 974 M | -107 M | -139 M | -132 M | -175 M | -187 M | -176 M | -170 M | -164 M | -129 M | -22.1 M | -78.1 M | -70.4 M | -74.4 M | -70.9 M | -57.5 M | -56.4 M | -38.1 M | -35 M | -30.7 M | -28.6 M | -24.1 M | -25.1 M | -16.9 M | -12.4 M | -9.47 M | -6.19 M | -5.79 M | - | -4.52 M | -4.66 M | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
-12 K | - | -55 K | -41 K | -188 K | - | 30 K | 45 K | -24 K | - | 31 K | 44 K | 35 K | - | 76 K | -66 K | 155 K | - | -8 K | 16 K | 4 K | - | 10 K | 32 K | -8 K | - | -23 K | -20 K | -5 K | - | -7 K | -7 K | -4 K | - | -6 K | -9 K | 5 K | - | -1 K | -5 K | - | - | 1 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-117 M | - | - | - | -155 M | - | -141 M | -128 M | -123 M | - | -127 M | -107 M | -93.9 M | 974 M | -106 M | -138 M | -131 M | -175 M | -186 M | -176 M | -169 M | -164 M | -128 M | -21.9 M | -77.9 M | -70.4 M | -74.3 M | -70.8 M | -57.2 M | -56.4 M | -37.9 M | -34.9 M | -30.7 M | -28.6 M | -24 M | -25 M | -16.9 M | -12.4 M | -9.44 M | -6.17 M | -5.78 M | - | -4.48 M | -4.63 M | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
126 M | - | 215 M | 173 M | 159 M | - | 143 M | 130 M | 125 M | - | 132 M | 110 M | 98.1 M | 135 M | 109 M | 140 M | 134 M | 177 M | 191 M | 177 M | 170 M | 164 M | 129 M | 112 M | 78.1 M | 70.4 M | 74.4 M | 70.9 M | 57.5 M | 56.4 M | 38.1 M | 35 M | 30.7 M | 28.6 M | 24.1 M | 25.1 M | 16.9 M | 12.4 M | 9.47 M | 6.19 M | 5.79 M | - | 4.52 M | 4.66 M | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
52.6 M | - | 78.1 M | 75.6 M | 65.7 M | - | 61.5 M | 52.4 M | 46.5 M | - | 48.7 M | 43.3 M | 39.8 M | - | 35.1 M | 38.2 M | 70.1 M | - | 88.5 M | 88.2 M | 83.9 M | - | 53.7 M | 43.2 M | 28.8 M | - | 16.1 M | 15 M | 12.3 M | - | 8.99 M | 8.91 M | 7.13 M | - | 6.6 M | 6.46 M | 4 M | - | 2.87 M | 1.81 M | 1.62 M | - | 1.11 M | 801 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung